• Science & Technology

More breast cancer patients than previously thought could benefit from existing targeted treatment

As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates. As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates.

13 March 2017

• Science & Technology

Gene editing stem cells with CRISPR could help understand brain tumours

For the first time, scientists have used the gene-editing tool CRISPR to tweak the DNA of specialised brain stem cells, which could help us understand certain brain tumours better. For the first time, scientists have used the gene-editing tool CRISPR to tweak the DNA of specialised brain stem cells, which could help us understand certain brain tumours better.

14 February 2017

• Science & Technology

The biology of cancer cell shape and why it’s important

Why is the shape of a cancer cell so important for predicting how the disease will behave? Our scientists may have an answer. Why is the shape of a cancer cell so important for predicting how the disease will behave? Our scientists may have an answer.

1 February 2017

• Science & Technology

Researchers reveal how cancer cells cope with genetic chaos

Scientists have uncovered how tumours are able to grow despite significant damage to the structure and number of their chromosomes - the storage units of DNA. Scientists have uncovered how tumours are able to grow despite significant damage to the structure and number of their chromosomes - the storage units of DNA.

9 January 2017

• Science & Technology

Targeting the cell’s master controller: Myc

Cancer Research UK scientists are finding ways to target the cell's 'master controller', which could have important implications for cancer treatment. Cancer Research UK scientists are finding ways to target the cell's 'master controller', which could have important implications for cancer treatment.

15 November 2016

• Science & Technology

Gene linked to brain defect could point to a new brain tumour drug target

Research into a rare genetic disease could help scientists understand a type of brain tumour. Research into a rare genetic disease could help scientists understand a type of brain tumour.

10 November 2016

• Science & Technology
• Health & Medicine

NCRI Cancer Conference 2016: Day 1 – lung cancer and yeast

We're in Liverpool for the annual National Cancer Research Institute (NCRI) Cancer Conference, sharing updates from the most exciting research on show. We're in Liverpool for the annual National Cancer Research Institute (NCRI) Cancer Conference, sharing updates from the most exciting research on show.

6 November 2016

• Science & Technology

The perfect match: making breast cancer treatment more personal

In the fourth of our series of posts for Stand Up To Cancer, we focus on a clinical trial that's finding faulty genes to improve breast cancer treatment. In the fourth of our series of posts for Stand Up To Cancer, we focus on a clinical trial that's finding faulty genes to improve breast cancer treatment.

21 October 2016

• For Researchers

A new era for pancreatic cancer: The Dream Team

We catch up with Professor Gerard Evan, a cancer genetics expert in Cambridge, to hear about his Stand Up To Cancer-funded work on pancreatic cancer. We catch up with Professor Gerard Evan, a cancer genetics expert in Cambridge, to hear about his Stand Up To Cancer-funded work on pancreatic cancer.

17 October 2016

• Science & Technology
• Health & Medicine

Improving treatments for childhood nerve cancer means understanding its complexity

New research points to a possible way to help personalise treatment for a type of childhood cancer. New research points to a possible way to help personalise treatment for a type of childhood cancer.

7 October 2016

• Science & Technology
• Health & Medicine

The trans-Atlantic quest to find a winning combination of cancer drugs

An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time. An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.

30 September 2016